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During development, neural cell fate in the vertebrate optic nerve is restricted to the astroglial lineage. However, when isolated from the
embryo and explanted in vitro, optic nerve progenitors generate neurons instead of astrocytes, suggesting that neuronal potentialities exist and are
repressed in progenitors in vivo. Here we have investigated the mechanisms controlling cell fate in the optic nerve. The optic nerve is
characterized by expression of the homeodomain transcription factor Pax2 which is maintained in differentiated astrocytes. We have observed that
Pax2 is rapidly down-regulated in explanted optic nerves that generate neurons, and that its overexpression by electroporation in the optic nerve,
or ectopically in the neural tube, is sufficient to block neuronal differentiation and allow glial development, showing that Pax2 plays a major role
in controlling cell fate in the optic nerve. In vitro and ex vivo experiments further show that a signaling cascade that involves successively Sonic
hedgehog and FGF is required to maintain Pax2 expression in optic nerve precursors whereby inhibiting the neuronal fate and promoting astroglial
differentiation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Optic nerve; Cell fate determination; Sonic hedgehog; FGF; Pax2; Neural tube; GliaIntroduction
The large variety of neuronal and macroglial cell types that
populate the vertebrate central nervous system (CNS) develop
from initially multipotent stem cells and/or progenitor cells of
the neuroepithelium (Temple, 2001). In most CNS areas, the
neural cell types locally generated are quite diverse and
comprise several classes of neurons and glial cells (for reviews,
see (Bertrand et al., 2002; Pearson and Doe, 2004). In a few
CNS areas, however, neural cell production is restricted to a
single cell type. Such is the case for a major component of the
forebrain, the optic nerve, a purely glial territory. In the adult,
the optic nerve entirely lacks neuronal cell bodies and comprises
astrocytes and oligodendrocytes that wrap retinal ganglion cell
axons on their way to the tectum. During development,
however, oligodendrocytes are not generated locally but arise
from extrinsic sources and migrate into the nerve in a proximo-
distal direction (Small et al., 1987; Ono et al., 1997). Thus, in
contrast to the neighboring retina, where neural progenitors⁎ Corresponding author. Fax: +33 561 55 65 07.
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one type of glia, optic nerve progenitors only produce
astrocytes. This has lead to the assumption that cell fate in
this region could be, from the onset, restricted to this particular
glial cell type (Small et al., 1987). However, it has been shown
that optic nerve precursors are not initially restricted to the
astroglial fate. In particular, when isolated from influences of
the surrounding tissues, optic nerve cells have the ability to
generate neurons (Omlin and Waldmeyer, 1989; Giess et al.,
1990), indicating that their developmental repertoire is broader
than their normal fate in vivo and that neuronal potentialities
must be repressed in this territory to allow only astrocytes to
develop.
The optic nerve arises from the optic stalk, a constriction of
the neuroepithelium connecting the optic vesicle to the
diencephalon. This neuroepithelial domain is characterized
from early stages by the specific expression of two home-
odomain transcription factors, Pax2 and Vax1 (Nornes et al.,
1990; Hallonet et al., 1998; Bertuzzi et al., 1999). Initial
expression of both factors is under the control of the Shh
signaling pathway (Chiang et al., 1996; Take-uchi et al., 2003).
Overexpression of Shh at early stages of eye formation expands
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Pax6 in the retina, resulting in severe malformations of the eye
(Ekker et al., 1995; Macdonald et al., 1995; Zhang and Yang,
2001; Take-uchi et al., 2003). Mutually repressive influences
between Pax2 and Pax6 have been well established, which
progressively contribute to the definition of sharp boundaries
between the retinal and optic nerve fields (Schwarz et al., 2000).
FGF signaling is another essential component in optic
system morphogenesis (de Iongh and McAvoy, 1993; Pittack et
al., 1997). FGF8, expressed in the retina (Vogel-Hopker et al.,
2000) and in the optic stalk (Crossley et al., 2001), has been
shown to direct retinal neuron specification (Martinez-Morales
et al., 2005). FGF signaling can also promote Vax gene
expression in the optic system (Take-uchi et al., 2003).
However, the role of FGF signaling in the development of the
optic stalk has not been investigated.
Pax2 and Vax1 play critical roles in eye morphogenesis, by
defining the identity of the optic stalk field. In mutant mice for
either factor, the retina–optic nerve boundaries are lost, leading
to the expansion the retinal field at the expense of the optic stalk
territory. In addition, the optic fissure does not close properly,
resulting in optic nerve coloboma (Favor et al., 1996; Torres et
al., 1996; Otteson et al., 1998; Bertuzzi et al., 1999; Hallonet et
al., 1999). In the Pax2 mutant, most optic stalk cells degenerate,
while a few differentiate into pigment cells (Schwarz et al.,
2000), whereas in the Vax1 mutant optic nerve glia seem to
develop normally, but fail to associate with axons, leading to
defects in retinal axon trajectories (Bertuzzi et al., 1999;
Hallonet et al., 1999).
Beyond initial morphogenesis, factors regulating cell fate in
the optic system have been well studied in the retina. For
example, Pax6 has been shown to control neuronal identity of
retinal precursors, since in conditional Pax6 mutant mice, in
which Pax6 is inactivated after initial retinal morphogenesis,
only amacrine cells develop at the expense of the other
neuronal types (Marquardt et al., 2001). In comparison, little is
known about cell fate regulation in the optic nerve. Loss of Shh
activity in the early chick and mouse optic system from its
retinal source modifies cell fate in the optic disk and distal part
of the optic nerve, leading either to neuronal development of
optic stalk neural precursors (Zhang and Yang, 2001) or to cell
death and pigment cell differentiation (Dakubo et al., 2003).
Possible functions for Pax2 and Vax1 in cell specification in the
optic nerve once morphogenesis is completed have not been
characterized.
In the present study, we have defined some of the factors
which repress neuronal differentiation in the embryonic chick
and mouse optic nerve and lead to glial fate restriction of optic
nerve precursors. We have focused on Pax2, and show that this
transcription factor is able to regulate neuronal/glial cell choice
in the optic nerve. Pax2 expression is lost in explanted optic
nerves that generate neurons. It is maintained by Shh activity
which in parallel totally blocks neuronal differentiation.
However, Shh effects are indirect and are mediated by FGF
signaling, suggesting that ongoing FGF activity is required to
inhibit neuronal differentiation and promote astroglial develop-
ment. Pax2 overexpression in optic nerve explants is sufficientto block neuronal differentiation and allow glial development.
Furthermore, ectopic expression of Pax2 in the trunk neural tube
also strongly inhibits neuronal development and induces glial
cells. We propose that a regulatory cascade involving
successively Shh, FGF and Pax2 regulates neuronal–glial cell
fate choice in the optic nerve.
Materials and methods
Fertilized White Leghorn chick eggs obtained from commercial source were
incubated at 38°C and staged according to the series of Hamburger and
Hamilton (Hamburger and Hamilton, 1992). Pax6Neu mutant mice (Small Eye
allele) were a gift of Pr. Dr. P. Gruss.
Dissections, cultures and treatments
Optic nerves of embryos were dissected free of surrounding tissues at
different stages (E4.5, E6 and E8) in sterile PBS. In all experiments, the whole
optic nerve was excised, but without contamination by retinal or diencephalic
tissues (see Results). At E4.5, optic nerves were grown as single explants. At
later stages, they were subdivided into two to three explants. Cultures were
grown on collagen gel-coated 12-mm plastic coverslips placed in 14-mm four-
well dishes (Nunc). The culture medium was Neurobasal supplemented with 1%
of B27 supplement (Gibco). The recombinant N-terminal fragment of the human
Shh protein (Biogen) was used at concentrations of 4, 12, 24, and 50 nM. The
recombinant mouse FGF8b and recombinant human FGF4 (R&D systems) were
used at 100 ng/ml. The recombinant human BMP protein (R&D Systems) was
used at a final concentration of 20 ng/ml. Cyclopamine, a gift of Dr. Frederic
Rosa (Ecole Normale Supérieure, Paris, France), was used at a concentration of
4 μM. SU5402 (Calbiochem) was used at a concentration of 50 μM. Some
experiments aiming to block the Shh signaling pathway were performed ex-
vivo. The head was dissected at E5, opened along the dorsal midline, leaving the
mesenchyme surrounding the optic nerve. These explants were then grown for
12 h with or without cyclopamine.
Staining procedures
For immunohistochemical analyses, heads of embryos were fixed in 3.7%
formaldehyde (Sigma) in PBS overnight at 4°C. Tissues were then sectioned at
80 μm on a vibratome (Leica) before being processed. Optic nerve explants were
fixed in the same fixative for 30 min at room temperature. O4 immunohis-
tochemistry was performed as previously described (Giess et al., 1992). For the
detection of intracellular antigens, fixed cultures and sections were first
permeabilized using Triton-X-100 (0.5% in PBS). Then they were blocked using
BSA (1% in PBS) and primary antibodies were applied at the appropriate
dilution in 0.1% Triton-X-100/BSA 1% in PBS and incubated overnight at 4°C.
After rinsing, they were incubated for 30 min with biotinylated secondary
antibody directed against either mouse or rabbit IG (Amersham, 1:50), followed
either by FITC or TRITC conjugates coupled to streptavidin (Amersham, 1:50).
In some cases, they were revealed for 1 h using goat anti-mouse or goat anti-
rabbit antibodies coupled to Alexa 488, Alexa 546, or Alexa 647 (Molecular
Probes). Apoptosis was detected by TUNEL staining using Cell Death Detection
Kit (Roche) as recommended by the manufacturer. Sections and optic nerve
explants were analyzed with either a Zeiss LSM-410 or a Leica SP2 confocal
microscope. Apoptosis was quantified by measuring mean pixel intensity in
optic nerve explants using image-J software.
Antibodies
Neurons were identified either with Tuj1 monoclonal antibody (Babco),
which recognizes neuron-specific β3-tubulin, used at 1/2000 or with NeuN
antibody (Chemicon), used at 1/500 or with anti HuC/D (Molecular Probes)
used at 1/500. Astroglial cells were evidenced by a rabbit antiserum directed
against the glutamate–aspartate transporter (GLAST), a gift from Dr. Masahiko
Watanabe used at 1/500. The anti-Pax2 antiserum (Babco) was used at 1/500
dilution. Mouse antibodies against Pax6, (used at 1:2) and HNK1 (used at 1:500)
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monoclonal O4 antibody (O4 mAb) (used at 1:4) was obtained from culture
supernatant of O4 hybridoma cells, a gift of Dr. R. Bansal. The AA3 antibody
directed against the DM20/PLP protein (used at 1:10) was provided by Dr. B.
Zalc.
In situ hybridization
Transcripts were analyzed using antisense digoxigenin RNA probe. The
chick cDNAs were Ngn2 (gift of Dr. D.J. Anderson), FGF8 (gift of Dr. S.
Martinez), Sprouty1 (gift of Dr. F. Pituello), Shh and Patched (gift of Dr. C.
Tabin), Slug (gift of Dr. M. Catala). The mouse cDNAs were Patched (gift of Dr.
M.P. Scott) and FGF8 (gift of Dr. S. Martinez). In situ hybridization was
performed as described in Wilkinson (1992), with minor modifications.
Hybridization of optic nerve explants cultures were carried out manually,
whereas hybridization of vibratome sections was performed with an in situ
hybridization robot (InsituPro, AbiMed).
In ovo electroporation
Complementary DNA for chick Pax2 was cloned into the two expression
vectors pIRES and pCIG. To generate Pax2-VP16 and Pax2-EnR fusion
constructs, PCR-amplified cDNA fragments that encode the transcriptional
activation domain of the viral protein VP16 (80 amino acids) (Triezenberg et al.,
1988), and the repressor domain of Drosophila Engrailed (330 amino acids)
(Smith and Jaynes, 1996) respectively, were fused to the N-terminus of the
homeodomain of chick Pax2. For neural tube electroporation, plasmidic DNA
solution (3 μg/μl) was injected into the lumen of HH stage 10 to 14 and of HH
stage 24 (E4.5) chick embryo neural tube. Electroporation was performed as
described (Nakamura and Funahashi, 2001). The pCS2-VP16 and pCS2-EnR
plasmids were also electroporated in control embryos. Embryos were harvested
and analyzed at HH stage 16 to 30 (E2.5 to E6.5). For electroporation into the
optic nerve, heads of E4 chick embryos were dissected to reveal the optic nerves
which were carefully separated from contaminating tissues. A 3 μg/μl DNA
solution was then injected into the lumen of the optic nerve. A pair of electrodes
was placed on either side of the optic nerve and 20 V of DC pulses were then
applied for 50 ms, 6–8 times by an Intercel electroporator. Optic nerves were
then separated from head tissues and cultivated on collagen coated dishes as
described above. In both optic nerve and neural tube electroporations, control
experiments with a GFP plasmid lacking the Pax2 construct were systematically
performed but never showed any perturbation in the development of the neural
structures or in cell differentiation.Results
Pax2 expression is inversely correlated with neuronal genesis
in the chick optic nerve
The optic nerve is purely gliogenic in vivo, but generates
neurons when isolated in vitro (Giess et al., 1990), providing
a simple paradigm to study neuronal versus glial cell fate
choice in this territory. To address the question of a possible
function of Pax2 in optic nerve cell specification, we first
examined its expression in intact and cultivated optic nerves.
Between E4 and E6 in vivo, Pax2 was expressed throughout
the optic nerve up to the optic nerve head (Fig. 1A), together
with the glial marker GLAST (Shibata et al., 1997; Hartfuss
et al., 2001) (Fig. 1D). In contrast, the retinal marker Pax6
(Fig. 1A), the proneural gene ngn2 expressed in the retina
(Fig. 1B), and the pan-neuronal markers NeuN and HuC/D (Fig.
1C) were all undetectable in the entire nerve, indicating that
neuroblasts or neurons do not pre-exist in the Pax2+ nerve
territory in vivo.Explantation of E4.5 chick optic nerves in vitro elicited
rapid neuronal development, as shown by strong ngn2
expression after 2 days in vitro (n=5/5; Fig. 1E) and extensive
neuronal differentiation after 6 days, monitored through TuJ1
or HuC/D expression (n=12/12; Figs. 1F, G and 2O). Control
RT-PCR experiments using two retinal specific markers, Pax6
and Chx10, showed that optic nerve explants were not
contaminated by retinal tissue (not shown). In contrast to the
optic nerve in vivo, astroglial differentiation, monitored using
the GLAST marker, was much reduced in all cases (n=9/9),
restricted to small areas of the explants (Fig. 1F). Interestingly,
in these experimental conditions Pax2 expression was rapidly
and strongly down-regulated. After 2 days in vitro, some cells
had already lost Pax2 expression and double-staining experi-
ments showed that they had started to express Pax6 (Fig. 1H).
After 6 days in vitro, only 16% of cells expressed Pax2 (n=6/6;
Figs. 1G and 2O) whereas Pax6 expression became prominent
(Fig. 1I). In addition, Tuj1 labeling indicated that all Pax6+
cells were neurons (n=3/3; Fig. 1J). These results indicate that
Pax2 expression in optic nerve cells is labile and is not
maintained when the nerve is isolated from its normal tissular
environment.
We also analyzed Pax2 expression in optic nerves explanted
at later developmental stages, which display reduced neuronal
potentialities (Giess et al., 1990). Most cells of the explants
(97%) expressed Pax2 (n=3/3; Fig. 1K), in correlation with
widespread expression of the astroglial maker GLAST (n=6/6;
Fig. 1L), whereas, as expected, very few neurons (3%)
differentiated in optic nerves explanted at E8 (Figs. 1K, L,
compare to Figs. 1F, G). Together, these results indicate that
optic nerve cells isolated from surrounding influences differ-
entiate into neurons at the expense of glial cell formation and
that Pax2 expression correlates positively with glial differentia-
tion and negatively with neuronal differentiation in the chick
optic nerve.
Shh and FGF abolish neuronal differentiation in the optic
nerve and maintain Pax2 expression
We next analyzed signaling factors that could be involved in
vivo in the inhibition of neuronal differentiation and main-
tenance of Pax2 expression and that could be lacking in
explanted optic nerves. We first examined the effect of Shh,
required for optic disc and stalk neuroepithelial cell differentia-
tion and which modulates Pax2 expression (Dakubo et al.,
2003). The entire nerve is under the influence of hedgehog
signaling as shown by uniform expression of Patched, the Shh
receptor and a direct response gene of this signaling system
(Dakubo et al., 2003 and not shown). However, Shh is not
expressed within the nerve itself. It is initially expressed in the
basal diencephalon and later on in retinal ganglion cells as they
differentiate (Jensen and Wallace, 1997). Consequently, Shh
signaling is lost de facto in optic nerves isolated in culture.
Strikingly, neuronal differentiation was strongly reduced in
E4.5 nerve explants cultivated in the presence of 4 nM Shh and
was practically abolished at 12 or 24 nM Shh (n=6/6; Figs. 2C,
D, O), compared to control explants (Figs. 2A, B, O). In
Fig. 1. Neuronal and glial differentiation and Pax2 expression in explanted embryonic chick optic nerves. (A–D) Frontal sections of the E6–E7 chick optic
system. (A) Double immunostaining for Pax2 (green) and Pax6 (red) shows that in vivo all cells of the optic nerve (on) express Pax2, whereas retinal ganglion
cells (ret) express Pax6. (B) In situ hybridization shows that ngn2 is not expressed in the E6 optic nerve, although it is prominently expressed in the retina. (C)
Immunostaining for HuC/D. Developing neurons are found in the retina, but not in the optic nerve. (D) Immunostaining for GLAST shows generalized
expression of the glial marker at E7. (E–J) Optic nerves were explanted from chicken embryos at E4.5 and cultivated for 2 days (E, H) or for 6 days (F, G, I, J).
(E) ngn2 becomes rapidly expressed in optic nerve explants 2 days after explantation. (F) Nerve explants display extensive neuronal differentiation as shown by
Tuj1 staining (red) of numerous cell bodies and profuse neurite outgrowth outside of the explant. GLAST staining (green), in contrast, is very limited. (G) Pax2 is
down-regulated and restricted to a very small subset of cells (green), while the vast majority of optic nerve cells have differentiated into HuC/D+ neurons (red).
(H) Two days after explantation, Pax2 expression (green) decreases and Pax6 expression (red) starts in optic nerve cells. Note that some cells co-express both
transcription factors (arrowheads). (I) After 6 days, most of the explant contains numerous Pax6+ cells (red), while Pax2 (green) is only maintained in a small
region. (J) In an E4.5 optic nerve explanted for 6 days, most Pax6+ cells express the neuronal marker Tuj1. Note, however, that some neurons do not express
Pax6 (arrowheads). (K, L) Optic nerves were explanted from chicken embryos at E8 and cultivated for 6 days. Neuronal differentiation (Tuj1 staining, red) is less
extensive and Pax2 (green) remains expressed in most optic nerve cells (K), while glial differentiation (L) monitored though GLAST expression (green) is more
extensive, compared to the previous stage (see (F)). (Scale bars, 50 μm in J, 100 μm in all other micrographs).
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out the explant (Fig. 2C), indicating generalized astrocyte
differentiation. Interestingly, Shh treatment also maintained
Pax2 expression in virtually all optic nerve cells (Figs. 2D, O,
compare with Fig. 2B).
We also examined the role of FGF8, a positive regulator of
Pax2 expression in the isthmus (Shamim et al., 1999), shown to
be expressed in the developing optic stalk (Crossley et al., 2001;
Aoto et al., 2002), but which function in this territory has not
been investigated. We found fgf8 mRNA expression in the
proximal part of the optic stalk as soon as at E2, which was
maintained at least up to E7 in the nerve (Fig. 2E). FGF
signaling was not restricted to the proximal optic nerve, sincewe found expression of the response gene sprouty1 throughout
the nerve (supplementary Fig. S1). However, fgf8 and sprouty1
expressions were not maintained in explanted E4.5 optic nerves
(n=4/4; Fig. 2F and supplementary Fig. S1), indicating that
factors extrinsic to the nerve are required to maintain this
signaling activity. We thus examined the effect of FGF8
treatment on explanted optic nerves. As with Shh, FGF8, or the
related FGF4 (not shown), abolished neuronal differentiation
(n=6/6; Figs. 2G, H, O) and maintained strong GLAST (Fig.
2G) and Pax2 (Figs. 2H, O) expressions. Together, these results
suggest that ongoing activities of both Shh and FGF signaling
pathways may be required in vivo to prevent neuronal differ-
entiation and maintain Pax2 expression.
Fig. 2. Control of the differentiation of optic nerve explants by morphogens. Chick optic nerves were explanted at E4.5 and cultivated for 6 days (A–D, G, H, K, L),
2 days (F, I, J) or for 3 days (M, N). (A–D) Compared to control explants (A, B), Shh treatment inhibits neuronal differentiation monitored by Tuj1 staining and
maintains strong GLAST (C) and Pax2 (D) expressions. (E, F) FGF8 is expressed in the proximal part of the E6 optic nerve (on, E). This expression is not maintained
after 2 days in E4.5 explanted optic nerves (F). (G, H) FGF8 treatment also inhibits neuronal differentiation (Tuj1 staining) and maintains GLAST (G) and Pax2 (H)
expressions. (I) Shh treatment maintains strong FGF8 expression in E4.5 nerves explanted for 2 days. (J) Conversely, FGF8 treatment is unable to promote Shh
expression in similar explants. (K, L) Compared to explants treated with Shh alone (C, D) or with FGF8 alone (G, H), co-treatment with Shh and the FGF-signaling
blocking agent Su 5402 restores neuronal differentiation and leads to reduced GLAST (K) and Pax2 (L) expressions, as in control conditions (A and B). This indicates
that the effect of Shh is mediated through FGF signaling. (M, N) TUNEL staining shows limited cell death in control (M) and Shh-treated (N) explants. (O)
Quantification of the relative proportions of neurons and Pax2+ cells developing in optic nerve explants in various conditions. Counts were performed on at least 3
different explants in each condition, double-stained with a neuronal marker (TuJ1 or HuC/D) and Pax2. Note that both Shh and FGF8 treatments practically abolish
neuronal differentiation, while co-treatment with Shh and SU 5402 restores this proportion to the level found in control conditions (Scale bars, 100 μm in all
micrographs).
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precursors
Members of the TGFβ superfamily (BMPs and activin) are
expressed in the dorsal retina (Trousse et al., 2001) and in the
head mesenchyme (Stern et al., 1995). We thus tested the
effect of BMP signaling, using BMP4 protein. BMP4
treatment (20 ng/ml) of E4.5 optic nerve explants for 6 days
was clearly deleterious for the survival of optic nerve
precursors, as all explants (5 to 7 explants in 4 different
experiments) were hypocellular. Analysis of apoptosis using
the TUNEL assay confirmed this observation and showed
massive cell death in BMP4-treated explants compared to
either untreated or Shh-treated explants, which displayed few
apoptotic cells distributed around their border (supplementary
Fig. S2A–D). Strikingly, BMP4 also induced the formation of
pigment cells in large areas of the explant (supplementary Fig.
S2E, F). Very few neurons formed and some of the remaining
non-pigmented cells expressed Pax2 and GLAST (supplemen-
tary Fig. S2G, H). Thus, in contrast to Shh and FGF8, BMP4
is not able to maintain the normal phenotype of the optic nerve
in vivo.Fig. 3. A Shh–FGF pathway maintains Pax2 expression in the optic nerve in vivo. D
(C–J). (A) In control conditions, fgf8 is expressed in the distal part of the optic nerv
(C–F) In control conditions, Pax2 is expressed normally throughout the nerve (C
coexpressed at the optic nerve/retina boundary, as shown in the overlay (F). (G–J
Furthermore, coexpression of Pax2 (H) and Pax6 (I) is observed in some cells (arrow
D–F and H–J).Epistatic relationships between Shh and FGF8 to maintain
Pax2 expression and to block neuronal differentiation
From the above results, we can infer that Shh and FGF8
could either work synergistically, or act upstream one of the
other. To distinguish between these possibilities, we analyzed
epistatic relationships between Shh and FGF expression in
explants. Shh treatment (12 nM) maintained robust fgf8 (n=6/
6) and sprouty1 (n=3/3) expressions in E4.5 optic nerves
explanted for 2 days (Fig. 2I and supplementary Fig. S1),
whereas FGF8 was totally unable to induce Shh expression
(n=3/3; Fig. 2J). The loss of fgf8 and sprouty1 expressions in
control conditions and their maintenance by Shh was not related
to cell death, since apoptosis, evidenced after 3 days in vitro
using the TUNEL assay was restricted to a few cells in the
explant and was similar in control and Shh-treated explants
(Figs. 2M, N and supplementary Fig. S2). Thus, Shh effect on
Pax2 expression could possibly be indirect and be mediated via
positive regulation of FGF8. To test this possibility, E4.5 optic
nerve explants exposed to Shh were treated with SU5402, a
FGF-signaling blocking agent (Mohammadi et al., 1997).
SU5402 treatment completely reversed the effect of Shh in itsissected E5 chick heads were maintained ex vivo for 12 h (A and B) or 2 days
es (dashed lines), whereas it is totally blocked after cyclopamine treatment (B).
). Remark that in these ex vivo conditions, Pax2 (D) and Pax6 (E) are not
) Su5402 treatment leads to drastic down regulation of Pax2 expression (G).
heads in (H–J)). (Scale bars, 200 μm in A and B, 50 μm in C and G, 10 μm in
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(n=7/7; Fig. 2K) expressions, leading to the typical extensive
neuronal differentiation found in control explants (Figs. 2K, L,
O). Conversely, treatment with cyclopamine, a potent inhibitor
of Shh signaling pathway (Incardona et al., 1998), was without
effect on the FGF-mediated maintenance of Pax2 expression
(n=3; not shown). Together, these results show that Shh activity
is a positive regulator of FGF8, which in turn maintains Pax2
expression in optic nerve cells.
To confirm whether a Shh–FGF pathway is responsible for
the permanence of Pax2 expression in the normal optic nerve
environment, we blocked either signaling pathway in vivo in
partially dissected heads of E5 embryos which maintain normal
expression of fgf8 and Pax2 (Figs. 3A, C). First, treatment for
12 h with cyclopamine to block Shh signaling totally inhibited
fgf8 expression (n=4/4; Fig. 3B), showing that endogenous Shh
activity is required to maintain FGF expression in the optic
nerve. Second, treatment of similar preparations for 2 days with
SU5402 caused a strong reduction in Pax2 expression in optic
nerve cells (n=4/4; Fig. 3G), showing that endogenous FGF
signaling is required to maintain Pax2 expression. Interestingly,
in SU5402-treated head explants, we observed Pax2–Pax6
double-labeled cells in the optic nerve (Figs. 3H–J) but not in
control head explants (Figs. 3D–F), indicating replacement of
Pax2 by Pax6, as observed in optic nerves isolated in vitro.
Together, these data show that in the developing optic nerve,
Shh activity is required to maintain FGF8 expression which in
turn controls Pax2 expression.Fig. 4. Pax2 overexpression inhibits neuronal differentiation and promotes GLASTex
the plasmids indicated in the captions, immediately explanted for 4 days and stai
differentiation (red) is not modified with a control GFP plasmid (green) (A, B), while
Pax2-GFP electroporated cells (green) do not differentiate into neurons, while neighb
(G, H) Composite panel of 4 different electroporated cells which show expression oPax2 inhibits neurogenesis in the optic nerve
In all the above experiments, Pax2 expression was inversely
correlated to the neurogenic potential of optic nerve cells,
suggesting that Pax2 itself could be responsible for inhibiting
the neuronal fate and promoting the glial fate in the optic nerve.
To directly address this question, we experimentally maintained
Pax2 expression in explanted nerves. A Pax2-GFP plasmid was
electroporated in E4.5 optic nerves just prior to explantation and
we analyzed the consequences on neuronal differentiation
4 days later. Electroporation of a control GFP plasmid did not
modify neuronal differentiation (n=8; Figs. 4A, B). In contrast,
Pax2-GFP electroporation resulted in all cases (n=6) in marked
inhibition of neuronal differentiation in the regions of the
explants successfully electroporated (Figs. 4C, D). Further-
more, none of the GFP+ electroporated cells expressed neuronal
markers (Figs. 4E, F), while many neurons differentiated from
non-electroporated cells. Most electroporated cells also
expressed the astroglial marker GLAST (Figs. 4G, H). Together,
this shows that forced expression of Pax2 in optic nerve
precursors results in cell autonomous inhibition of the neuronal
fate and induction of the glial fate.
As shown above, in isolated optic nerves Pax2 expression is
rapidly replaced by Pax6 in cells that differentiate along the
neuronal lineage. The mutual transcriptional repression activ-
ities of Pax2 and Pax6 (Schwarz et al., 2000), and the role of
Pax6 in neuronal specification in the retina (Marquardt et al.,
2001), raised the possibility that Pax2 function in inhibitingpression in explanted optic nerves. Optic nerves were electroporated at E4.5 with
ned with Tuj1 (A–D), HuC/D (E, F) or GLAST (G, H) antibodies. Neuronal
it is strongly reduced with a Pax2-GFP plasmid (C, D). At higher magnification,
oring non-electroporated cells express the neuronal marker HuC/D (red) (E, F).
f the glial marker GLAST. (Scale bars, 100 μm in A–D, 25 μm in E–H).
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neurogenic function of Pax6. We addressed this possibility in
a direct manner by using the seyNeu mouse mutants, which carry
a null allele of Pax6, and in which the development of the optic
system is abortive (Grindley et al., 1995). If Pax6 activity was
required for neuron formation, neurons would not develop from
the mutant optic nerve. At E12.5–E13.5, Patched and FGF8
expressions, which were readily detected in wild type mice
(Figs. 5A, C) were maintained in the abortive optic cup and optic
nerve of sey/sey mutants (Fig. 5B, D), suggesting that Shh and
FGF signalings are preserved in the mutant. Indeed, we also
found Pax2 expression in the remnant optic system of the mutant
(Figs. 5E, F), confirming previous observations (Grindley et al.,
1995). We then examined neuronal potentialities in the mutant
optic system by explanting the optic system rudiment carefully
microdissected at E12.5. Explants of wild type embryonic optic
nerves were used as controls. In all cases (n=4), explants from
either mutant (Fig. 5H) or wild type (Fig. 5G) animals displayedFig. 5. Analysis of transcriptional activities of Pax2 in the mouse and chick embryo. (
mice. (A–D) In situ hybridization shows that Patched and FGF8, normally expressed in
(B, D). (E, F) Pax2 expression in the wild-type optic nerve (E) is also maintained throu
optic system of Pax6 mutant mice (Sey/Sey) (H), were explanted at E12.5 and culti
generate numerous Tuj1+ neurons (red) and limited GLAST+ glial cells (green). (H)
(red). Note that Pax2 expression (green) is almost totally absent from the explant. (I–L)
VP16 fusion plasmids. (I, J) Pax2-EnR fusion plasmid does not modify neuronal diffe
shown by coexpression of GFP (green) and HuC/D (red), leading to yellow cytoplasm
number of HuC/D+ neurons in the electroporated area. Note that none of the Pax2-VP1
100 μm in A–H, 25 μm in I–L).extensive neuronal differentiation, accompanied by a strong
down regulation of Pax2 expression (Fig. 5H). Thus, Pax6
activity does not seem required for neuronal development in
explanted optic nerves, suggesting that Pax2 does not block
neuronal development through Pax6 inhibition.
Pax2 may exert its transcriptional functions not only through
repression but also through activation of target genes (Dehbi et
al., 1996; Brophy et al., 2001, 2003). To further analyze its
transcriptional activity, we constructed fusion proteins of the
pax2 gene with either the transcriptional repressor domain of
Drosophila engrailed (Pax2-EnR) or with the herpes simplex
virus protein 16 transactivation domain (Pax2-VP16). Each of
these forms was again electroporated in the optic nerve just
prior to explantation. Many cells electroporated with the Pax2-
EnR fusion adopted a neuronal phenotype (n=8/8; Figs. 5I, J)
showing that the repressive form of Pax2 had no effect on
neuronal differentiation. In contrast, the Pax2-VP16 fusion
phenocopied the wild type protein, reducing the number ofA–F) Frontal sections of E13.5 wild type (A, C, E) and sey/sey mutant (B, D, F)
wild type embryos (A, C), are also expressed in the mutant abortive optic system
ghout the mutant optic system (F). (G, H) Optic nerve of wild type mice (G) and
vated for 6 days. (G) As in the chick embryo, explanted wild type optic nerves
Similarly, the explanted mutant optic system generates numerous Tuj1+ neurons
Electroporation in the chick optic nerve of Pax2-engrailed (Pax2-EnR) and Pax2-
rentiation. Note that Pax2 electroporated cells have differentiated into neurons, as
(arrowheads). (K, L) In marked contrast, Pax2-VP16 fusion plasmid lowers the
6-GFP+ cells (green) have differentiated into HuC/D+ neurons (red). (Scale bars,
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entiated as neurons (n=7/7; Figs. 5K, L). Together, these results
indicate that maintaining Pax2 activity is sufficient to inhibit
neuronal differentiation in the optic nerve territory and that
Pax2 exerts this effect as a transcriptional activator.
Ectopic expression of Pax2 in the neural tube inhibits
neurogenesis and promotes gliogenesis through transcriptional
activation
To assess whether Pax2 can control neuronal and glial cell
fate choice outside the particular tissular context of the opticFig. 6. Pax2 ectopic expression in the neural tube down-regulates Pax6 and inhibits n
E1.5 neural tube and embryos analyzed 24 (A–F) or 48 (G, H) h later. (A, B) and (E–
cells (green) superimposed to the marker analyzed (red), and on the right expression of
down-regulated the expression of Pax6 (A, B). (D) Pax2 reduced expression of ngn2 o
embryo (C), suggesting inhibition of neuronal specification. (E, F) Maximum projecti
decrease in neuronal cell bodies evidenced through Tuj1 staining. (G, H) Transverse E
cell bodies at the level of electroporated cells. (I) Mean number of neurons, stained
sections from control embryos (n=4), electroporated with the GFP plasmid and from
GFP+ cell bodies were taken into account. Pax2 electroporation caused a 70% decrsystem, we determined its effect when ectopically expressed in
the trunk neural tube. In this region, Pax2 is never expressed in
neural precursors and thus is not involved in neuronal versus
glial cell choice. It is restricted to post-mitotic interneurons
(Burrill et al., 1997) and plays a role in their differentiation
(Cheng et al., 2004). The Pax2-GFP plasmid was electroporated
in the trunk neural tube of stage 10–12 embryos, which were
fixed and examined 24 h to 4 days later.
We first observed that Pax2 electroporation efficiently
blocked Pax6 expression (n=4/4; Figs. 6A, B), indicating that
in the spinal cord as in the optic system and in the forebrain
(Matsunaga et al., 2000; Schwarz et al., 2000), Pax2 inhibitseuronal differentiation. Pax2-GFP bicistronic plasmid was electroporated in the
H) are image pairs of the same section showing on the left GFP+ electroporated
the marker alone. The electroporated side is on the right in all micrographs. Pax2
n the electroporated side, compared to the control side or to a non-electroporated
on of horizontal confocal sections of an electroporated embryo. Note the dramatic
4 spinal cord section stained with HuC/D antibody. Note the absence of neuronal
with Tuj1 antibody, counted 24 h after electroporation on transverse spinal cord
experimental embryos (n=4), electroporated with the Pax2-GFP plasmid. Only
ease in neuron formation. Error bars represent S.E.M. (Scale bars, 50 μm).
809C. Soukkarieh et al. / Developmental Biology 303 (2007) 800–813Pax6 expression.We then analyzed neuron formation throughout
the neural tube, using ngn2 as a marker of neuronal precursors
and a battery of pan-neuronal markers. Pax2 electroporation
considerably down-regulated the expression of ngn2 (n=2/2;
Figs. 6C, D) and reduced the number of neurons recognized by
Tuj1 (n=6/6; Figs. 6E, F), HuC/D (n=4/4; Figs. 6G, H) or Neu-
N (not shown), irrespective of their position along the dorso-
ventral axis of the neural tube. Quantification taking into account
cells efficiently electroporated, monitored either through GFP
expression or Pax2 immunoreactivity, indicated a 70% reduction
in the number of differentiated neurons (Fig. 6I). This inhibition
of neuronal development was accompanied by the systematic
induction of glial markers including O4 (n=6/6; Figs. 7A, B), a
marker of oligodendrocytes and Schwann cells and of the myelin
marker PLP/DM20 (n=3/3; Figs. 7C, D), but not of astroglial
markers GFAP and GLAST (not shown). Further analysis with
lineage markers such as HNK1 (n=5/5; Figs. 7E, F), Slug (not
shown) and Sox9 (n=4/4; Figs. 7G, H) suggested that Pax2
electroporated cells had evolved along a Schwann-type lineage
fate. In all experiments, control embryos electroporated with a
GFP plasmid never displayed modification in neuronal differ-
entiation and induction of glial markers. Together, these results
indicate that in ectopic situation, Pax2 is also able to inhibit the
neuronal fate and to induce the glial fate.
The transactivating and repressive constructs of Pax2, Pax2-
VP16 and Pax2-EnR were also misexpressed in the neural tube.
The Pax2-EnR fusion phenocopied the intact protein in its
inhibitory effect on Pax6 expression (Fig. 8A), but had no effectFig. 7. Pax2 ectopic expression in the neural tube induces differentiation of Schwann-
Transverse spinal cord sections were stained 24 h (A, B, E–H) or 4 to 5 days (C, D
expression in a subset of neuroepithelial cells. Note that only cells expressing Pax2 als
GFP+ cells express PLP/DM20. Note that some cells have migrated in the margin
aggregate (D). (E, F) GFP+ cells express the HNK1 epitope, irrespective of their dorso
suggesting weak or transient induction of the expression of this transcription factor.on either neuronal or glial differentiation (Figs. 8B, C). In
contrast, the Pax2-VP16 fusion did not inhibit Pax6 expression
(Fig. 8D), but phenocopied all the other effects of Pax2,
including strong inhibition of pan-neuronal markers (Fig. 8E)
and induction of glial markers (Fig. 8F). Electroporation of
control pCS2-EnR and pCS2-VP16 plasmids were without
effect (not shown). Thus, as in the optic nerve, Pax2 protein
inhibits neuronal differentiation and promotes glial development
from neural progenitors through activation of transcription.
Discussion
Precursor cells that populate the optic nerve only give rise to
astrocytes in vivo but display an intrinsic neuronal potential
when isolated in vitro. Here, we have investigated mechanisms
regulating the neuronal versus glial cell fate choice in the optic
nerve.We show that the homeodomain transcription factor Pax2,
which characterizes the optic nerve territory and later on optic
nerve astrocytes, represses the neuronal fate and promotes the
glial fate. We also show that Pax2 expression is labile in optic
nerve cells and is maintained in this CNS area by a signaling
cascade involving successively Shh and FGF activities.
The intrinsic neuronal potential of optic nerve precursors has
already been observed in chick (Giess et al., 1990, 1992) and
rodents (Juurlink and Fedoroff, 1980; Omlin and Waldmeyer,
1989). In the chick embryo, this potential is extremely high in
optic nerves isolated at early developmental stages (e.g. E4–
E5), most cells differentiating into neurons, and very few intolike cells. (A–H) Electroporations of Pax2/GFP plasmid in the E1.5 neural tube.
) later. (A, B) Double-staining for Pax2 (blue) and O4 (red). Pax2 induces O4
o express O4, suggesting a cell autonomous effect. (C, D) At E5 (C) and E6 (D),
al zone (C), while others remained in the neuroepithelium and formed a small
-ventral level in the spinal cord. (G, H) A subset of the GFP+ cells express Sox9,
(Scale bars, 50 μm in A, B and E, F; 25 μm in C, G, H; 10 μm in D).
Fig. 8. Pax2 inhibits the neuronal fate and promotes the glial fate through transcriptional activation. Pax2-engrailed fusion (Pax2-EnR) and Pax2-VP16 fusion were
electroporated in the E1.5 neural tube and transverse spinal cord sections were stained 24 h later. (A–C) In the neural tube, Pax2-EnR down-regulated expression of
Pax6 (A) but was without effect on neuronal differentiation (B) and on glial induction (C). (D–F) In contrast, Pax2-VP16 did not affect Pax6 expression (D), but
inhibited neuronal differentiation (E) and promoted formation of O4+ glial cells (F). Arrowheads delineate the neural tube areas electroporated. (Scale bar, 50 μm in all
micrographs).
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progressive increase in astroglial differentiation, suggesting that
neuronal differentiation in the explants occurs at the expense of
glial differentiation. Thus, presumably precursors are at least
bipotential and progressively loose their ability to differentiate
into neurons as they become engaged along the astroglial
pathway. Interestingly, neural stem cells which can give rise to
neurons have been observed in the adult rat optic nerve (Palmer
et al., 1999), suggesting that neuron-competent precursors
persist throughout life in this CNS region.
Optic nerves isolated in vitro and deprived of Shh signaling
generate neurons whereas exogenous Shh suppresses neuronal
differentiation. This indicates that ongoing Shh signaling is
required until late in development for correct cell differentiation
in the nerve. In support of this, injections of Shh neutralizing
antibodies in the early chick optic system cause neuronal
differentiation in the most distal part of the optic stalk (Zhang
and Yang, 2001). A role for Shh in controlling cell fate in the
optic disk and optic stalk has also been observed in the mouse.
Conditional Shh gene ablation in mouse retinal ganglion cells
lead to the lack of astrocyte development in the optic disk and
distal part of the optic stalk, showing the important role of Shh
transported along retinal axons in controlling the fate of these
neural precursors (Dakubo et al., 2003). However, in these Shh-
deprived nerves, neuronal development was not reported.
Instead, the nerve was hypocellular and was surrounded by
pigment cells. One possible reason for the discrepancy between
the results of Dakubo et al. (2003) and our own findings may bethat in vivo, optic stalk precursors are the target of other
signaling systems, including factors of TGFβ superfamily
(BMPs and activin) expressed in the dorsal retina (Trousse et al.,
2001) and in the head mesenchyme (Stern et al., 1995). The
present data show that chick optic nerve explants cultivated in
the presence of BMP4 form very few neurons and are
hypocellular and pigmented, a phenotype reminiscent of that
found in the mutant mice. Therefore, our data suggest that the
intrinsic fate of optic nerve precursors is to form neurons. In the
presence of Shh alone, neuronal specification is abolished,
whereas in the absence of Shh and in the presence of BMPs,
precursors are diverted from the neuronal fate, some undergoing
apoptosis and the other becoming pigment cells.
An important observation from the present study is that the
function of Shh signaling on cell fate appears indirect and is
relayed by the FGF signaling pathway. At least three lines of
evidence support this view. First, Shh is required to maintain
FGF8 expression in the optic nerve; second, FGF signaling,
mediated by FGF8 (and also by FGF4), mimics Shh activity and
is sufficient to block neuronal differentiation in isolated nerves.
Finally, Shh-mediated suppression of neuronal differentiation in
explanted nerves is abolished by blocking FGF signaling.
Altogether, these data are consistent with the idea that Shh is
required to maintain FGF activity within the nerve, which in
turn is primarily responsible for inhibiting the neuronal fate. In
zebrafish embryos, FGF3 and FGF17 in addition to FGF8 have
also been identified in the optic stalk (Reifers et al., 2000;
Walshe and Mason, 2003). Whether FGF8 is the only member
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remains to be determined. There are few examples of a positive
control of FGF expression by Shh. A positive feed-back loop
between FGF and Shh signaling systems has been shown in the
limb bud, but little is known regarding similar relationships in
the nervous system (see Wilson and Maden, 2005, for
references). In Shh mutant mice, FGF8 expression is reduced
in the forebrain, but it was unclear whether this was due to
inhibition of expression or to apoptosis of FGF-producing cells
(Ohkubo et al., 2002). In our system, explanted optic nerves
grown without Shh displayed down regulation of FGF8
expression but negligible apoptosis. This indicates that the
loss of FGF8 expression was not due to cell death and that most
probably Shh maintains FGF8 expression at the level of its
transcription. The mechanisms by which Shh maintains FGF8
expression remain to be elucidated. Analysis of Gli3−/−; Shh−/−
double mutant mice show maintained FGF8 expression in the
early neural tube, leading to the suggestion that FGF8
expression could be regulated independently of Shh (Aoto et
al., 2002). This discrepancy could be explained by the fact that
FGF8 expression becomes dependent on Shh signaling in the
optic nerve at later developmental stages, possibly involving a
balance between activator (Gli1/2) and repressor (Gli3) forms of
Gli activity. Alternatively, Indian hedgehog, expressed along
the optic stalk (Wallace and Raff, 1999), could complement for
Shh loss of function.
We observed that FGF activity was required to maintain
Pax2 expression in optic nerve cells. Relationships between
Pax2 and FGF8 have been well exemplified in the isthmus.
Pax2, one of the earliest genes expressed in this structure, is
required and sufficient to induce FGF8 expression (Ye et al.,
2001), which itself, subsequently, is required to maintain Pax2
expression. In addition, FGF8 overexpression in the anterior
neural tube induces ectopic expression of Pax2 (Crossley et al.,
1996; Shamim et al., 1999). In FGF8 conditional mutants, Pax2
expression is reduced, possibly due to cell death (Chi et al.,
2003). In such mutants, however, the phenotype of the optic
nerve has not been studied (Meyers et al., 1998). Interestingly,
Gli3−/− mutant mice show up-regulation of FGF8, accompanied
by an extension of Pax2 expression in the Pax6 retinal domain
(Aoto et al., 2002). Together, these data indicate that one of the
main roles of FGF signaling in the optic nerve is to maintain
Pax2 expression.
In the present experiments, performed well after eye
morphogenesis has been completed, Pax2 function alone
appears sufficient to inhibit the neuronal fate and promote
astrocyte development in the optic nerve. The murine optic
system is also characterized by expression of other home-
odomain transcription factors, Vax1 in the optic stalk and Vax2
in the ventral retina (Hallonet et al., 1998; Barbieri et al.,
1999). Combined inactivation of Vax1 and Vax2 leads to the
transformation of the optic nerve into retina and it has been
suggested that both factors play an early role in eye
morphogenesis by repressing synergistically Pax6 expression
in the optic nerve, allowing development of the retinal field
(Mui et al., 2005). However, Vax1 does not seem to play a role
in the specification of optic nerve cells, since in the singleVax1 mutant, despite formation of a coloboma and major
defects in optic tract formation, optic nerve glia seems to form
normally and Pax2 expression is maintained (Bertuzzi et al.,
1999; Hallonet et al., 1999). The Drosophila homolog of Pax2,
sparkling (D-Pax2), also plays important roles in eye
development, where it is required for the proper specification
of non-neuronal cells in late larval and pupal eye discs (Fu and
Noll, 1997) and in the specification of support cells of
mechanosensory organs in the drosophila peripheral nervous
system (Kavaler et al., 1999). These data suggest a conserved
function of Pax2 between invertebrates and vertebrates in the
specification of non-neuronal cells. This is also strongly
supported by the consequences of Pax2 ectopic expression in
the neural tube where it inhibited neuron formation and
induced the glial fate, both effects being mediated through
transcriptional activation. Strikingly, in the particular context
of the trunk neural tube, ectopic expression of Pax2 did not
promote the astrocyte fate, but instead induced the formation
of Schwann-like cells, identified as such by the expression of
neural crest lineage and myelin markers (HNK1, Slug, Sox9,
O4 and PLP/DM20). The mechanism underlying the induction
of this particular cell type remains to be determined. Never-
theless, it is possible that it involves initially induction of Sox9
expression, as this gene, when ectopically expressed in the
chick neural tube, has been shown to inhibit neuronal
differentiation and to promote Schwann cell formation
(Cheung and Briscoe, 2003). Interestingly, Sox9 loss of
function leads to enhanced neuronal differentiation at the
expense of oligodendroglial and astroglial development (Stolt
et al., 2003). Irrespective of the mechanism involved, it should
be stressed that during normal in vivo development of the
trunk neural tube, Pax2 function is not related to the
generation of glial cells but to the differentiation of neuronal
phenotypes (Cheng et al., 2004).
The mechanism of action of Pax2 in the optic nerve
remains to be established. Our experiments with Pax6 mutant
mice show that neurons develop readily from optic rudiment
explants in the absence of Pax6. Thus Pax2 function cannot be
simply explained by its known repression of the Pax6 gene
(Schwarz et al., 2000). Furthermore, our molecular dissection
using Pax2 chimeric proteins shows that inhibition of the
neuronal fate results from transcriptional activation of target
genes. Thus, other factors activated downstream of Pax2 are
probably involved in this repression, for example Hes or Id
genes, known to block neuronal specification and promote the
glial fate (Morrison et al., 2000; see also Bertrand et al.,
2002).
In conclusion, our present results indicate that Pax2 can act
both as an inhibitor of neurogenesis and as an inducer of
gliogenesis in the optic nerve. They support the notion that in
the optic system Pax2 may be able to control a switch
mechanism between neuronal and glial fates.
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